J
Jaap W. Deckers
Researcher at Erasmus University Rotterdam
Publications - 273
Citations - 39450
Jaap W. Deckers is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Myocardial infarction & Heart failure. The author has an hindex of 68, co-authored 268 publications receiving 37766 citations. Previous affiliations of Jaap W. Deckers include European Society of Cardiology & Hannover Medical School.
Papers
More filters
Journal Article
Abstract 5066: The Treatment Effect of Perindopril is Consistent in All Patients with Vascular Disease or High Risk of Vascular Disease: A Combined Analysis of Three Perindopril Trials
Jasper J. Brugts,Eric Boersma,Jaap W. Deckers,Willem J. Remme,Michel E. Bertrand,Kim Fox,Roberto Ferrari,Maarten L. Simoons +7 more
TL;DR: The beneficial effect of the ACE-inhibitor perindopril has been demonstrated in large placebo-controlled clinical trials consisting of patients with stable CAD without overt heart failure (EUROPA),...
Journal Article
Adverse psychological outcome in women with coronary artery disease.
TL;DR: These results add to current knowledge on gender differences and show that women have an adverse outcome on a range of psychological variables, which has implications for secondary prevention and rehabilitation.
Journal ArticleDOI
Statins and All-Cause Mortality in High-Risk Primary Prevention of Patients With Cardiovascular Risk Factors
Jasper J. Brugts,Jaap W. Deckers +1 more
TL;DR: A twodozen–lined chapter titled “Predicitive Appearance of Preclinical Evaluation” indicated that clinical evaluation can be limited to the check of the results of the specific test bench, and there is no concern for clinical end points such as mortality and morbidity, effectiveness, and the collection of postapproval data.
Journal ArticleDOI
Implementation of the 2015 European Society of Cardiology guidelines for the management of infective endocarditis in the Netherlands
Ali R. Wahadat,Jaap W. Deckers,Ricardo P.J. Budde,J. T.M. van der Meer,E. H. Natour,J. ten Oever,A. L.J. Kortlever-van der Spek,B. H. Stegeman,Nelianne J. Verkaik,Jolien W. Roos-Hesselink,Wilco Tanis +10 more
TL;DR: It was concluded that most ESC recommendations for IE management could be endorsed, albeit with some adjustments, and the Stichting Werkgroep Antibioticabeleid (SWAB) guidelines for IE treatment instead of the antibiotic regimens proposed by the ESC.